China Medical System Joins PRC’s Drug Distribution Rollup

China Medical System Holdings will pay almost $200 million to acquire Tianjin Precede Medical Trade Development Co., a fellow drug distributor in China. CMS said the transaction will give it new products to sell and a larger sales network. Like other PRC drug distribution companies, CMS is following the well-trodden path of IPOing on the Hong Kong exchange and using the proceeds to continue the steady rollup of China’s pharma distribution networks. More details.... Stock Symbol: (HK: 867)     Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});